Skip to main content
. 2021 Oct 20;12:705583. doi: 10.3389/fmicb.2021.705583

FIGURE 3.

FIGURE 3

Putative primary and secondary cysteine-degrading bacteria are more prevalent than (SRB) among individuals with IBD, CRC, and healthy controls. Relative abundances of putative cysteine-degrading bacteria and sulfate-reducing bacteria across healthy and diseased populations. Relative abundances were calculated using Kraken2 (Wood et al., 2019) (see section “Materials and Methods”). (A) Data obtained from curatedMetagenomicData (Pasolli et al., 2017). Number of samples per disease category: control = 560, CRC = 352, adenoma = 143, IBD = 148. (B) Data obtained from HMP2 (Almeida et al., 2020). Number of samples per disease category: non-IBD = 359, ulcerative colitis (UC) = 367, Crohn’s disease (CD) = 591. (C) Data obtained from PRISM (Franzosa et al., 2019). Number of samples per disease category: control = 56, UC = 76, CD = 88. (D) Data obtained from study on Pediatric Crohn’s Disease (Lewis et al., 2015). Number of samples per disease category: control = 26, CD = 86.